Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
1.27
- 0.05 (-3.79%)
2:20 PM ET on Sep 19, 2017
Delayed at least 20 minutes.
Day High 1.35
Day Low 1.27
52-Week High 27.36
Volume 235,195
Print Friendly